• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Consumers

  • Print
  • Share
  • E-mail

Blood Products Advisory Committee

Topic: Reclassification of Human Immunodeficiency Virus (HIV) drug sensitivity assays.
Date: 09/17/1999
Committee: Blood Products Advisory Committee

The agency described the general classification of biological products, and asked the committee for a recommendation for classification of viral resistance assays. The classification assignment determines how these assays are regulated by the agency.